Verinata Health
Redwood City · Founded 2002
About Verinata Health
Verinata is driven by a sole, extraordinary purpose ’ maternal and fetal health. Our initial focus is to develop and offer non-invasive tests for early identification of fetal chromosomal abnormalities using our proprietary technologies. We aim to reduce the anxiety associated with today's multi-step process, the unacceptable false-positive rates, the non-specific and sometimes confusing results of current prenatal screening methods, as well as the risk of current invasive procedures. In support of national guidelines recommending first trimester aneuploidy risk assessment, we believe women who desire such an assessment should be offered a single blood draw test with a definitive result. Verinata is conducting a prospective, blinded pivotal study to clinically validate the sensitivity and specificity of its first prenatal test on a large scale with results of the study expected in 2011.
Company Facts
- Founded: 2002
- Legal name: Verinata Health, Inc
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $87.5M
- Funding stage: M&A
- Last round: Series C (Aug 2011)
- Website: verinata.com
- Phone: (650)632-1680
Social Profiles
Canonical: https://fsome.com/organization/verinata-health-8276715 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.